Literature DB >> 7621344

Regulation of renal calbindin-D28K: the role of calcitonin.

C Hemmingsen1, M Staun, E Lewin, K Olgaard.   

Abstract

Infusion of calcitonin lowers circulating calcium, but in the distal tubule of the kidney, pharmacological doses of calcitonin increase the active calcium reabsorption. Calbindin-D28k plays a significant role in the calcium reabsorption in the distal convoluted tubule of the kidney. The effect of calcitonin on renal calbindin-D28k in relation to calcium metabolic changes was therefore examined. In study 1, thyroparathyroidectomy followed by autotransplantation of the parathyroid glands (TX) was compared with a sham operation in rats. TX reduced plasma calcitonin from 54 +/- 2 to 9 +/- 1 pg/ml (P < 0.001), whereas ionized calcium and parathyroid hormone were returned to the control value after an initial decrease, indicating a successful implantation of the parathyroid glands. No changes were seen in calbindin-D or plasma 1,25(OH)2D. In study 2, subcutaneous infusion of salmon calcitonin 2.5 U/kg/hour via osmotic pumps was compared with infusion of vehicle in rats. Ionized calcium was reduced from 1.37 +/- 0.01 to 1.33 +/- 0.02 mmol/liter (P < 0.05), whereas no changes were seen in renal or intestinal calbindin-D or in plasma 1,25(OH)2D. After TX, only calcitonin decreased whereas the other calcium metabolic parameters showed no change. This indicates that in rats, selective elimination of calcitonin does not influence other parameters of the calcium metabolism and that the effect of calcitonin on calcium transport in the distal tubule is not mediated via an increase in renal calbindin-D28k.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621344     DOI: 10.1007/bf00301605

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  22 in total

1.  Loss of calcemic effects of calcitonin and parathyroid hormone infused continuously into rats using the Alzet osmotic minipump.

Authors:  J F Obie; C W Cooper
Journal:  J Pharmacol Exp Ther       Date:  1979-06       Impact factor: 4.030

2.  Regulation of plasma calcium and phosphate in calcitonin-infused rats.

Authors:  S Lausson; P Tracqui; L Toubiana; G Milhaud; A M Perault-Staub; J F Staub
Journal:  Am J Physiol       Date:  1990-09

3.  CaBPr facilitates intracellular diffusion for Ca pumping in distal convoluted tubule.

Authors:  F Bronner; W D Stein
Journal:  Am J Physiol       Date:  1988-09

4.  Calcium-binding protein biosynthesis in the rat: regulation by calcium and 1,25-dihydroxyvitamin D3.

Authors:  M Buckley; F Bronner
Journal:  Arch Biochem Biophys       Date:  1980-06       Impact factor: 4.013

5.  Control of cyclic adenosine 3',5'-monophosphate production in osteoclasts: calcitonin-induced persistent activation and homologous desensitization of adenylate cyclase.

Authors:  G C Nicholson; J M Moseley; A J Yates; T J Martin
Journal:  Endocrinology       Date:  1987-05       Impact factor: 4.736

6.  Ca2+-binding protein from human kidney. Purification and properties.

Authors:  M Staun; O Norén; H Sjöström
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

7.  Enzyme-linked immunoadsorbent assay (ELISA) for calcium-binding protein of human small intestine. A quantitative method for measuring calcium-binding protein in small intestinal biopsies.

Authors:  M Staun
Journal:  Clin Chim Acta       Date:  1986-09-30       Impact factor: 3.786

8.  Effects of magnesium on renal and intestinal calbindin-D.

Authors:  C Hemmingsen; M Staun; K Olgaard
Journal:  Miner Electrolyte Metab       Date:  1994

9.  Calcium metabolic changes and calbindin-D in experimental hypertension.

Authors:  C Hemmingsen; M Staun; E Lewin; M Egfjord; K Olgaard
Journal:  J Hypertens       Date:  1994-08       Impact factor: 4.844

10.  Effect of calcitonin on calcium and magnesium transport in rat nephron.

Authors:  G A Quamme
Journal:  Am J Physiol       Date:  1980-06
View more
  1 in total

1.  Calbindins decreased after space flight.

Authors:  I N Sergeev; W B Rhoten; M D Carney
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.